Windtree Therapeutics Inc (OTCQB:WINT)

3.75
Delayed Data
As of May 18
 0.00 / 0.00%
Today’s Change
2.28
Today|||52-Week Range
20.00
-10.71%
Year-to-Date
Institutional investors purchased a net $162.6 thousand shares of WINT during the quarter ended December 2017 and now own 6.66% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Other institutional6.65%
Mutual fund holders0.02%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Windtree Therapeutics Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Broadfin Capital LLC3.86%145,387545,201+102,667+240.33%
Deerfield Management Company LP1.89%71,111266,666+58,041+444.08%
Alyeska Investment Group LP0.90%34,029127,609+1,862+5.79%
Rockefeller & Co., Inc.0.02%5772,164+577--
The MassMutual Trust Co., FSB0.00%1400.00%

Top 10 Mutual Funds Holding Windtree Therapeutics Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Nikko Asset Global Medical Strate...0.02%5772,164+577--